ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs
English Health Press Release

ISSAR Pharma Announces Out-Licensing of Its Peptide-Based NCEs

ISSAR Pharma, the only company in India which focuses on the research and development of New Chemical Entities (NCE), is licensing out its NCEs based on peptide technology, opening opportunities for fruitful partnerships. Hyderabad (Telangana)…